Search results
Author(s):
Sunil Kapur
,
Moussa Mansour
Added:
3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting more than three million Americans.1 The management of AF revolves around the alleviation of symptoms related to an accelerated and irregular ventricular response, and the prevention of cardioembolism, notably stroke. In patients with AF, there is a fivefold increased incidence of embolic stroke.2 The prevention of systemic…
View more
Author(s):
Wern Yew Ding
,
Dhiraj Gupta
Added:
3 years ago
AF is associated with an increased risk of thromboembolic events.1,2 Risk scores are used to identify patients at high risk of such complications who may benefit from anticoagulation therapy.3 However, despite a broad range of anticoagulant options and improved uptake in anticoagulation over the past decade, there are limitations to this approach. First, there is a significant proportion of high…
View more
Jacqueline Saw
Job title: Clinical Associate Professor
Author
Convergent AF Ablation
Author(s):
Karan Wats
,
Andy Kiser
,
Kevin Makati
,
et al
Added:
3 years ago
Article
Author(s):
Prof Georg Nickenig
,
Jur ten Berg
Added:
5 years ago
Author(s):
Michala Sejr
Added:
5 years ago
Dr Michala Sejr (Institut for Klinisk Medicin, Herning, DK) discusses comparison of simultaneous two-day external loop recording and Holter monitor recording for detection of atrial fibrillation in patients after acute ischemic stroke or transient ischemic attack
Filmed by Radcliffe Cardiology on-site at ESC 2018
View more
Author(s):
Thorsten Hanke, MD
Start date:
Nov 18, 2023
This live stream will be presented during the following session:
Session 9: Interesting and challenging cases
Case 4, presented by Thorsten Hanke, MD
Moderator: Lars Sondergaard, MD / Stefan Bertog, MD
Panelist: Bushra Rana, MD / Vijay Swarup, MD
View more
Added:
3 years ago
Dr Shephal Doshi (Pacific Heart Institute, Santa Monica, CA, US) discusses the results from the PINNACLE FLX Study.
The PINNACLE FLX Study is a prospective, non-randomized, multi-center investigation to establish the safety and effectiveness of the WATCHMAN FLX™ Left Atrial Appendage Closure Device for subjects with non-valvular atrial fibrillation who are eligible for long-term anti-coagulation…
View more